Dopamine D2L receptor knockout mice display deficits in positive and negative reinforcing properties of morphine and in avoidance learning

Neuroscience

Volumn 113, Issue 4, 2002, Pages 755-765

  Smith, J W ^a,b   Fetsko, L A ^a   Xu, R ^a   Wang, Y ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Active avoidance; Cocaine; Conditioned place aversion; Conditioned place preference; Dopamine D2L receptor knockout mice; Morphine withdrawal

Indexed keywords

COCAINE; DOPAMINE 2 RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; NALOXONE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; DRUG ABUSE; DRUG WITHDRAWAL; ELECTROSTIMULATION; KNOCKOUT MOUSE; LEARNING TEST; MALE; MEMORY CONSOLIDATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TRAINING; WILD TYPE; WITHDRAWAL SYNDROME;

ANIMALS; AVOIDANCE LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MORPHINE; MOTOR ACTIVITY; RECEPTORS, DOPAMINE D2; REINFORCEMENT (PSYCHOLOGY); SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0037055980     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(02)00257-9     Document Type: Article

References (46)

1. Agmo A., Galvan A., Talamantes B. Reward and reinforcement produced by drinking sucrose - two processes that may depend on different neurotransmitters. Pharmacol. Biochem. Behav. 52:1995;403-414.
2. Agmo A., Marroquin E. Role of gustatory and postingestive actions of sweeteners in the generation of positive affect as evaluated by place preference conditioning. Appetite. 29:1997;269-289.
3. Caine S.B., Negus S.S., Mello N.K., Bergman J. Effects of dopamine D(1-like) and D(2-like) agonists in rats that self-administer cocaine. J. Pharmacol. Exp. Ther. 291:1999;353-360.
4. Castellano C., Cestari V., Cabib S., Puglisi Allegra S. Post-training dopamine receptor agonists and antagonists affect memory storage in mice irrespective of their selectivity for D1 or D2 receptors. Behav. Neural Biol. 56:1991;283-291.
5. Cervo L., Samanin R. Effects of dopaminergic and glutamatergic receptor antagonists on the acquisition and expression of cocaine conditioning place preference. Brain Res. 673:1995;242-250.
6. Dal Toso R., Sommer B., Ewert M., Herb A., Pritchett D.B., Bach A., Shivers B.D., Seeburg P.H. The dopamine D2 receptor: two molecular forms generated by alternative splicing. EMBO J. 8:1989;4025-4034.
7. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. USA. 85:1988;5274-5278.
8. Dickinson A., Smith J.W., Mirenowicz J. Dissociation of pavlovian and instrumental incentive learning under dopamine antagonists. Behav. Neurosci. 114:2000;468-483.
9. Emerich D.F., Sanberg P.R. Neuroleptic dysphoria. Biol. Psychiatry. 29:1991;201-203.
10. Fiorino D.F., Coury A., Fibiger H.C., Phillips A.G. Electrical-stimulation of reward sites in the ventral tegmental area increases dopamine transmission in the nucleus-accumbens of the rat. Behav. Brain Res. 55:1993;131-141.
11. Galkina O.V., Podgornaya E.K. Regional brain patterns of dopamine, metabolites and D-2 receptors in memory. Pharmacol. Biochem. Behav. 54:1996;453-460.
12. Giros B., Sokoloff P., Martres M.P., Riou J.F., Emorine L.J., Schwartz J.C. Alternative splicing directs the expression of two D2 dopamine receptor isoforms. Nature. 342:1989;923-926.
13. Higgins G.A., Nguyen P., Sellers E.M. The NMDA antagonist dizocilpine (MK801) attenuates motivational as well as somatic aspects of naloxone precipitated opioid withdrawal. Life Sci. 50:1992;1167-1172.
14. Hyman S.E. Addiction to cocaine and amphetamine. Neuron. 16:1996;901-904.
15. Koob G.F., Sanna P.P., Bloom F.E. Neuroscience of addiction. Neuron. 21:1998;467-476.
16. Koob G.F., Simon H., Herman J.P., Le Moal M. Neuroleptic-like disruption of the conditioned avoidance response requires destruction of both the mesolimbic and nigrostriatal dopamine systems. Brain Res. 303:1984;319-329.
17. Kosten T.A., DeCaprio J.L., Nestler E.J. Long-term haloperidol administration enhances and short-term administration attenuates the behavioral effects of cocaine in a place conditioning procedure. Psychopharmacology. 128:1996;304-312.
18. Mack K.J., O'Malley K.L., Todd R.D. Differential expression of dopaminergic D2 receptor messenger RNAs during development. Dev. Brain Res. 59:1991;249-251.
19. Mack K.J., Todd R.D., O'Malley K.L. The mouse dopamine D2A receptor gene: sequence homology with the rat and human genes and expression of alternative transcripts. J. Neurochem. 57:1991;795-801.
20. Maldonado R., Saiardi A., Valverde O., Samad T.A., Roques B.P., Borrelli E. Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature. 388:1997;586-589.
21. Matthes H.W.D., Maldonado R., Simonin F., Valverde O., Slowe S., Kitchen I., Befort K., Dierich A., Le Meur M., Dolle P., Tzavara E., Hanoune J., Roques B.P., Kieffer B.L. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene. Nature. 383:1996;819-823.
22. Monsma F.J.Jr., McVittie L.D., Gerfen C.R., Mahan L.C., Sibley D.R. Multiple D2 dopamine receptors produced by alternative RNA splicing. Nature. 342:1989;926-929.
23. Morency M.A., Beninger R.J. Dopaminergic substrates of cocaine-induced place conditioning. Brain Res. 399:1986;33-41.
24. Parker L.A., Joshi A. Naloxone-precipitated morphine withdrawal induced place aversions: Effect of naloxone at 24 hours postmorphine. Pharmacol. Biochem. Behav. 61:1998;331-333.
25. Pruitt D.L., Bolanos C.A., McDougall S.A. Effects of dopamine D1 and D2 receptor antagonists on cocaine-induced place preference conditioning in preweanling rats. Eur. J. Pharmacol. 283:1995;125-131.
26. Rasmussen K., Kendrick W.T., Kogan J.H., Aghajanian G.K. A selective AMPA antagonist, LY293558, suppresses morphine withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal. Neuropsychopharmacology. 15:1996;497-505.
27. Robinson T.E., Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev. 18:1993;247-291.
28. 1 receptor in the cocaine-induced conditioned place preference. NeuroReport. 11:2000;2885-2888.
29. Saint-Cyr J.A., Taylor A.E., Lang A.E. Procedural learning and neostriatal dysfunction in man. Brain. 111:1988;941-959.
30. Salamone J.D. The involvement of nucleus accumbens dopamine in appetitive and aversive motivation. Behav. Brain Res. 61:1994;117-133.
31. Schechter M.D., Calcagnetti D.J. Continued trends in the conditioned place preference literature from 1992 to 1996, inclusive, with a cross-indexed bibliography. Neurosci. Biobehav. Rev. 22:1998;827-846.
32. Schultz W., Dayan P., Read Montague P. A neural substrate of prediction and reward. Science. 275:1997;1593-1599.
33. iα proteins. J. Biol. Chem. 269:1994;23120-23127.
34. Shannon H.E., Hart J.C., Bymaster F.P., Calligaro D.O., Delapp N.W., Mitch C.H., Ward J.S., Fink-Jensen A., Sauerberg P., Jeppesen L., Sheardown M.J., Swedberg M.D.B. Muscarinic receptor agonists, like dopamine receptor antagonist antipsychotics, inhibit conditioned avoidance response in rats. J. Pharmacol. Exp. Ther. 290:1999;901-907.
35. Shippenberg T.S., Heidbreder C. Sensitization to the conditioned rewarding effects of cocaine: pharmacological and temporal characteristics. J. Pharmacol. Exp. Ther. 273:1995;808-815.
36. Silva A.J., Simpson E.M., Takahashi J.S., Lipp H.-P., Nakanishi S., Wehner J.M., Giese K.P., Tully T., Abel T., Chapman P.F., Fox K., Grant S., Itohara S., Lathe R., Mayford M., McNamara J.O., Morris R.J., Picciotto M., Roder J., Shin H.-S., Slesinger P.A., Storm D.R., Stryker M.P., Tonegawa S., Wang Y., Wolfer D.P. Mutant mice and neuroscience: recommendations concerning genetic background. (Banbury Conference on Genetic Background in Mice). Neuron. 19:1997;755-759.
37. Sora I., Wichems C., Takahashi N., Li X.-F., Zeng Z., Revay R., Lesch K.-P., Murphy D.L., Uhl G.R. Cocaine reward models: Conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice. Proc. Natl. Acad. Sci. USA. 95:1998;7699-7704.
38. Squire L.R., Knowlton B., Musen G. The structure and organization of memory. Annu. Rev. Psychol. 44:1993;453-495.
39. Tzschentke T.M. Measuring reward with the conditioned place preference paradigm: A comprehensive review of drug effects, recent progress and new issues. Prog. Neurobiol. 56:1998;613-672.
40. Uhl G., Blum K., Noble E., Smith S. Substance abuse vulnerability and D2 receptor genes. Trends Neurosci. 16:1993;83-88.
41. Vukhac K.-L., Sankoorikal E.-B., Wang Y. Dopamine D2L receptor- and age-related reduction in offensive aggression. NeuroReport. 12:2001;1035-1038.
42. Wang, Y., Xu, R., Sasaoka, T., Sankoorikal, E.-B., 2002. Dopamine D2L receptor knockout mice provides a unique model system for studying the functions of D2L and D2S. In: Catecholamine Research: From Molecular Insights to Clinical Medicine: Proceedings of the Ninth International Catecholamine Symposium. Kluwer Academic/Plenum, New York, in press.
43. Wang Y., Xu R., Toshikuni S., Tonegawa S., Kung M.-P., Sankoorikal E.-B. Dopamine D2 long receptor-deficient mice display alterations in striatum-dependent functions. J. Neurosci. 20:2000;8305-8314.
44. Wise R.A. Neurobiology of addiction. Curr. Opin. Neurobiol. 6:1996;243-251.
45. Xu, R., Hranilovic, D., Fetsko, L.A., Bucan, M., Wang, Y., 2002a. Dopamine D2S and D2L receptors may differentially contribute to the actions of antipsychotic and psychotic agents in mice. Mol. Psychiatry, in press.
46. Xu R., Parlow A.F., Wang Y. The effects of dopamine and D2 receptor antagonists on pituitary hormone secretion are intact in mice lacking dopamine D2L receptor. Brain Res. 939:2002b;95-99.